Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
European Journal of Haematology
|
September 1, 1996
Analysis of the p53 and MDM-2 gene in acute myeloid leukemia
B Seliger, S Papadileris, D Vogel, et al.
Annals of Hematology
|
August 1, 1993
IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P)
F Hladik, K Kolbe, E U Irschick, et al.
Respiratory Medicine
|
July 23, 2017
Budesonide + formoterol delivered via Spiromax<sup>®</sup> for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler<sup>®</sup>
A Lewis, S Torvinen, P N R Dekhuijzen, et al.
Annals of Hematology
|
April 1, 1996
Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol
A Ganser, A Maurer, C Contzen, et al.
Blood
|
April 1, 1996
Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3
K Geissler, C Peschel, D Niederwieser, et al.
British Journal of Haematology
|
December 21, 2000
Short Report: Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen
C Craddock, P Bardy, S Kreiter, et al.
Bone Marrow Transplantation
|
August 18, 2009
Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation
R G Meyer, E M Wagner, A Konur, et al.
Annals of Hematology
|
February 9, 2000
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)
A Ganser, G Heil, G Seipelt, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics
|
February 13, 2018
Corrigendum to "LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease" [BBAPAP 1865 (6) (2017) 703-714]
A Schrötter, A Oberhaus, K Kolbe, et al.
Annals of Hematology
|
May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
W K Hofmann, G Heil, C Zander, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
European Journal of Haematology
|
September 1, 1996
Analysis of the p53 and MDM-2 gene in acute myeloid leukemia
B Seliger, S Papadileris, D Vogel, et al.
Annals of Hematology
|
August 1, 1993
IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P)
F Hladik, K Kolbe, E U Irschick, et al.
Respiratory Medicine
|
July 23, 2017
Budesonide + formoterol delivered via Spiromax<sup>®</sup> for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler<sup>®</sup>
A Lewis, S Torvinen, P N R Dekhuijzen, et al.
Annals of Hematology
|
April 1, 1996
Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol
A Ganser, A Maurer, C Contzen, et al.
Blood
|
April 1, 1996
Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3
K Geissler, C Peschel, D Niederwieser, et al.
British Journal of Haematology
|
December 21, 2000
Short Report: Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen
C Craddock, P Bardy, S Kreiter, et al.
Bone Marrow Transplantation
|
August 18, 2009
Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation
R G Meyer, E M Wagner, A Konur, et al.
Annals of Hematology
|
February 9, 2000
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)
A Ganser, G Heil, G Seipelt, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics
|
February 13, 2018
Corrigendum to "LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease" [BBAPAP 1865 (6) (2017) 703-714]
A Schrötter, A Oberhaus, K Kolbe, et al.
Annals of Hematology
|
May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
W K Hofmann, G Heil, C Zander, et al.
Page
of 5